Transgene site of integration dictates clonal stability and the long term transcriptional activity of gene of interest in recombinant CHO cells. In this presentation, we will discuss the application of targeted locus amplification (TLA) technology to identify genomic sites of transgene integration and integrity of transgene sequence itself to assess the suitability of recombinant CHO clones as a candidate for generating candidate therapeutic lysosomal enzyme for pre-clinical studies.
Presenter: Vishal Agrawal, PhD, Scientist II, Cell and Molecular Biology, Biomarin Pharmaceutical Inc.
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter